Please login to the form below

Not currently logged in


This page shows the latest cost-effectiveness news and features for those working in and with pharma, biotech and healthcare.

NICE rejects Sanofi’s Dupixent for atopic dermatitis at first call

NICE rejects Sanofi’s Dupixent for atopic dermatitis at first call

Dupixent is still too expensive despite discount, says the UK’s cost effectiveness body. ... The agency said that while the clinical evidence shows that dupilumab is effective when used in this way, its cost-effectiveness estimates “compared with

Latest news

More from news
Approximately 3 fully matching, plus 517 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    In August 2017, Novartis announced that Kymriah would be $475, 000 per treatment, which caused a lot of headlines, but was actually lower than many analysts were expecting; a cost-effectiveness ... Indeed, the cost-effectiveness evidence for many

  • Digital

    Healthcare terms - Digital.

  • Public relations

    Healthcare terms - Public relations.

  • Drug pricing

    Healthcare terms - Drug pricing.

  • Healthcare systems

    Healthcare terms - Healthcare systems.

More from intelligence
Approximately 0 fully matching, plus 50 partially matching documents found.

Latest appointments

  • Former NICE chair joins board of biotech Former NICE chair joins board of biotech

    The former chair of England's cost-effectiveness body for medicines, Sir Michael Rawlins, has made a contentious move to the US biotech Intra-Cellular Therapies as member of its board ... His expertise in the cost-effectiveness of new pharmaceuticals and

  • Executive changes at Teva as community and institutional affairs division launched

    Referencing Teva's previous record in compliance, Dr De Notaristefani said: “ We will continue this practice as we begin to set the industry standard for regulatory compliance, customer service and cost ... effectiveness.”. Teva launches community

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Webinar: What next for biosimilars?

    Biosimilar medicines appear to present a significant opportunity to introduce cutting-edge therapies to the treatment landscape for many diseases, while also addressing the cost-effectiveness demands now being made on

  • Digital is different – why new marketing technologies require new ways of working

    More engaging materials? Better market understanding? More ROI? Cost-effectiveness? All those are great goals but there’ s one thing to demand of digital technology beyond all the others: individual relevancy.

  • The Heart of the Matter 7: Reality Dawns

    to use it to demonstrate effectiveness in the real-world setting,” says Mariam Bibi, director of realworld evidence, Complete True Life. “ ... It's all about making the right Connections.". Key Takeaways. HTA Bodies and regulators are placing an

  • Quality Personnel

    Quality Personnel. Established in 1987, Quality Personnel Services Limited set out to provide a reputation for quality, integrity and cost effectiveness.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....